Formula No. 2 Plus K Liq 2 mg Liquid is a Health Canada–registered human drug (DIN 02048256) held by Golden Pride/Rawleigh, containing Ascorbic Acid. Health Canada lists its status as Cancelled Post Market (status date 30 Sep 1996). Nexara Health has matched 397 registrations of Ascorbic Acid across 20 other regulated markets.

Health Canada registration

Ascorbic Acid registered in other markets

397 registrations of the same molecule in 20 national registries outside Canada (first 107 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Ascorbic Acid worldwide →

Regulator price references for Ascorbic Acid

Published list or reimbursement prices for Ascorbic Acid presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Formula No. 2 Plus K Liq (DIN 02048256) marketed in Canada?

No. Health Canada lists DIN 02048256 as Cancelled Post Market as of 30 Sep 1996.

Who holds the Canadian licence for this product?

Golden Pride/Rawleigh is the company of record in the Health Canada Drug Product Database.

Is Ascorbic Acid registered outside Canada?

Yes — Nexara Health has matched 397 registrations in 20 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02048256, status date 1996-09-30; national medicine registries: ANMDMR nomenclator, BDA, DH Drug Office, DoH SEP database, EDE, FDA NDC, HSA, JFDA drug registrations, Laegemiddelstyrelsen, LINAME (formulary), Medicines Authority, MISPAS, NHRA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: DoH SEP database, EDE, NHRA, SFDA. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02048256, status date 1996-09-30; national medicine registries: ANMDMR nomenclator, BDA, DH Drug Office, DoH SEP database, EDE, FDA NDC, HSA, JFDA drug registrations, Laegemiddelstyrelsen, LINAME (formulary), Medicines Authority, MISPAS, NHRA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: DoH SEP database, EDE, NHRA, SFDA.

Health Canada Drug Product Database (DPD), DIN 02048256, status date 1996-09-30; national medicine registries: ANMDMR nomenclator, BDA, DH Drug Office, DoH SEP database, EDE, FDA NDC, HSA, JFDA drug registrations, Laegemiddelstyrelsen, LINAME (formulary), Medicines Authority, MISPAS, NHRA, NHS dm+d VMP, NPRA, SFDA, SUKL DLP, TFDA, TITCK, URPL RPL; price sources: DoH SEP database, EDE, NHRA, SFDA. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.